Concepedia

Author

Paul Moser

Porsolt (France)ORCID

Also Known As

Moser, P C Moser, P MOSER, P Moser, P. C. Moser, P. Moser, P.C. Moser, PAUL C. MOSER, Paul C Moser, Paul C. Moser

97

Publications

4.4K

Citations

33

H-Index

107

Concepts

All Affiliations

Porsolt (France)University of BathCentre National de la Recherche Scientifique
PM

About

Paul Moser is an author at Porsolt (France) specializing in medicine, neuroscience, and social sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

34

3.1K

2

Social Sciences

19

22

2.6K

3

Health Sciences

7

7

424

4

Anesthesia

3

3

139

5

Public Health

1

1

135

Paul Moser

×

45

Publications

3.8K

Citations

29

H-Index

YearCitations

Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice

Vincent Castagné, Paul Moser, Sylvain Roux,

Current Protocols in Neuroscience

2011

686

Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice

Vincent Castagné, Paul Moser, Sylvain Roux,

Current Protocols in Pharmacology

2010

462

Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein.

Paula M. Moran, Linda S. Higgins, Barbara Cordell,

Proceedings of the National Academy of Sciences

1995

336

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

Paul Moser

Psychopharmacology

1989

188

Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area

Eric Charpantier, Pascal Barnéoud, Paul Moser,

Neuroreport

1998

168

Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse

Vincent Castagné, Roger D. Porsolt, Paul Moser

European Journal of Pharmacology

2009

147

Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies

A Blondel, D. J. Sanger, Paul Moser

Psychopharmacology

2000

135

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

Michael G. Palfreyman, Christopher J. Schmidt, Stephen M. Sorensen,

Psychopharmacology

1993

125

Characterization of MDL 73005EF as a 5‐HT<sub>1A</sub> selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8‐OH‐DPAT and diazepam

Paul Moser, Mark D. Tricklebank, Derek N. Middlemiss,

British Journal of Pharmacology

1990

113

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist

Paul Moser, Paula M. Moran, Robert Frank,

Behavioural Brain Research

1995

112

Page 1